Testosterone use in the United States tripled from 2001 through 2011, mostly in men without a clear indication.1,2 In late 2013 and early 2014, 2 studies reported increased myocardial infarction and stroke associated with testosterone use.3,4 The US Food and Drug Administration (FDA) issued a safety bulletin on January 31, 2014. We assessed recent trends in testosterone prescribing.
Baillargeon J, Kuo Y, Westra JR, Urban RJ, Goodwin JS. Testosterone Prescribing in the United States, 2002-2016. JAMA. 2018;320(2):200–202. doi:10.1001/jama.2018.7999
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: